Search for: "Watson Pharmaceuticals Inc."
Results 141 - 160
of 224
Sort by Relevance
|
Sort by Date
21 Apr 2011, 3:09 pm
©2011 Amaxx Risk Solutions, Inc. [read post]
12 Apr 2011, 9:37 pm
• Defendants: Watson Laboratories Inc.; Watson Pharmaceuticals Inc.; Watson Pharma Inc. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive… [read post]
28 Mar 2011, 9:59 pm
By Donald Zuhn -- On Friday, in Duramed Pharmaceuticals, Inc. v. [read post]
27 Mar 2011, 9:28 pm
Watson Laboratories, Inc. [read post]
25 Mar 2011, 8:29 pm
" Duramed Pharmaceuticals v. [read post]
22 Mar 2011, 4:21 pm
General New IP resource for Pharma, Biotech and Chem – Compulsory licences, comparing national requirements (IP Think Tank) WIPO and India partner to protect traditional knowledge from misappropriation (WIPO) UN Rapporteur for the Right to Health asked to intervene in the TPP negotiation (KEI) Patents and doctors, and the USTR TPP text (KEI) Biotech industry losing interest in the therapeutic potential of RNAi (Patent Docs) India: The curious case of the ‘data exclusivity’ volte… [read post]
17 Mar 2011, 7:47 am
Watson Pharmaceuticals Inc., et. al., 1-08-cv-00330 (DED March 11, 2011, Order) (Robinson, J.) [read post]
14 Mar 2011, 4:31 am
From a press release, Morristown, NJ, 14 March 2011:Watson Pharmaceuticals, Inc. , today announced that the United States District Court for the District of Delaware has ruled that Watson's generic version of Fentora® (fentanyl buccal tablets C-II) does not infringe United States Patent Nos. 6,200,604 or 6,974,590 (the '604 and '590 Patents) and that the '604 and '590 Patents are invalid. [read post]
15 Feb 2011, 5:26 pm
(FDA Law Blog) Diovan (Vasartan) – France: Novartis v Actavis – preliminary injunction for Valsartan confirmed (The SPC Blog) Diovan HTC (Valsartan) – Belgium: Antwerp Court of Appeal stops infringement of Valsartan/HCTZ SPC based on patent claiming Valsartan alone: Novartis v Teva (The SPC Blog) Lescol (Fluvastatin) – US: Novartis files patent infringement complaint against Mylan following Para IV challenge (Patent Docs) (GenericsWeb) Mucinex (Guaifenesin) – US:… [read post]
15 Feb 2011, 4:57 pm
©2011 Amaxx Risk Solutions, Inc. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
19 Jan 2011, 3:23 pm
©2010 Amaxx Risk Solutions, Inc. [read post]
19 Jan 2011, 2:44 pm
The case goes back to $398 million that Bayer allegedly paid Watson Pharmaceuticals Inc., Barr Laboratories Inc. and others supposedly in exchange for the companies not marketing lower-cost generic versions of the antibiotic Cipro. [read post]
22 Dec 2010, 3:01 am
Watson Laboratories, Inc. [read post]
13 Dec 2010, 11:41 am
©2010 Amaxx Risk Solutions, Inc. [read post]
12 Dec 2010, 9:47 pm
Hunt • Defendants: IMPAX Laboratories, Inc.; Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc. [read post]
10 Dec 2010, 2:31 pm
Watson Laboratories, Inc., C.A. [read post]
8 Dec 2010, 6:07 pm
Other GnRH drugs include Watson Pharmaceuticals Inc's Trelstar and Endo Pharmaceuticals Holdings Inc's Vantas. [read post]
6 Dec 2010, 10:56 am
©2010 Amaxx Risk Solutions, Inc. [read post]
